SCHEMBL5213554

SCHEMBL5213554

COc1cccc(S(=O)(=O)N2c3ccccc3-c3ccc(F)cc3C2C)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.47
TSHR P16473 1/20 0.47
MAPK1 P28482 1/20 0.47
PSEN1 P49768 9/20 0.43
PSEN2 P49810 9/20 0.43
APH1B Q8WW43 9/20 0.43
NCSTN Q92542 9/20 0.43
APH1A Q96BI3 9/20 0.43
PSENEN Q9NZ42 9/20 0.43
MEN1 O00255 1/20 0.43
GFER P55789 1/20 0.43
KMT2A Q03164 1/20 0.43
RAB9A P51151 1/20 0.41
GPR183 P32249 1/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
CTSG P08311 1/20 0.39
CMA1 P23946 1/20 0.39
PKM P14618 1/20 0.39
PKLR P30613 1/20 0.39
AURKA O14965 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5213235 0.93 PSEN1 (0.47) LMNATSHRMAPK1PSEN1PSEN2
SCHEMBL5212451 0.91 PSEN1 (0.45) LMNATSHRMAPK1PSEN1PSEN2
SCHEMBL4950250 0.90 PSEN1 (0.49) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL4950261 0.90 PSEN1 (0.49) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL5211077 0.90 PSEN1 (0.49) LMNAPSEN1PSEN2APH1BNCSTN
SCHEMBL5210367 0.89 PSEN1 (0.48) LMNATSHRMAPK1PSEN1PSEN2
SCHEMBL5213066 0.87 PSEN1 (0.47) LMNATSHRMAPK1PSEN1PSEN2
SCHEMBL5211420 0.86 USP2 (0.47) LMNATSHRMAPK1PSEN1PSEN2
SCHEMBL5214670 0.86 PSEN1 (0.44) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL5212960 0.85 PSEN1 (0.51) LMNATSHRMAPK1PSEN1PSEN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1567502-B1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES WYETH CORP (US) 2007-08-22 EP disclosed
EP-1567502-A1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES Wyeth (US) 2005-08-31 EP disclosed
US-6894061-B2 Substituted dihydrophenanthridinesulfonamides WYETH (US) 2005-05-17 US disclosed
US-20040167155-A1 Substituted dihydrophenanthridinesulfonamides WYETH 2004-08-26 US disclosed
WO-2004050631-A1 SUBSTITUTED DIHYDROPHENANTHRIDINESUL FONAMIDES WYETH (US) 2004-06-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167155-A1 Substituted dihydrophenanthridinesulfonamides TNNT2, TNNI3, SIRT5 LMNA 4711/4885TSHR 2351/4885MAPK1 370/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.